News and Press Releases
Press releases
Theralase’s Latest Research on Anti-Cancer Technology Accepted for Presentation at International Conference
Press ReleaseToronto, Ontario, January 29, 2015 / Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink(R)) announced today that its latest research on its lead Photo Dynamic Compound (“PDC“) TLD-1433 binding to transferrin has been ...
Theralase Files US Patent Application for Increased Targeting of Photo Dynamic Therapy
Press ReleaseToronto, Ontario – January 20, 2015, Theralase Technologies Inc. (“Theralase”)(TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has filed a provisional US patent application for “Transferrin Enhanced Photo Dynamic Therapy (...
Theralase Identifies Lead Photo Dynamic Compound for Human Clinical Trials
Press ReleaseToronto, Ontario – January 15, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has identified its lead Photo Dynamic Compound (“PDC”) that it plans to enter into a Health C...
Theralase to Present at Alpha North Investor Conference
Press ReleaseToronto, Ontario – January 13, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that Roger Dumoulin-White, President and CEO of Theralase will present at the 2nd Annual AlphaNorth Capit...
Theralase Summarizes its 2014 Scientific Achievements and 2015 Strategic Objectives
Press ReleaseToronto, Ontario – January 9, 2015, Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today a summary of its 2014 scientific achievements published in peer reviewed, high impact scientific journals ...
Theralase Reports Results of PDC Therapy of Bladder Cancer in Orthotopic Rat Model
Press ReleaseToronto, Ontario – December 23, 2014, Theralase Technologies Inc. (“Theralase”)(TLT:TSXV) (TLTFF: OTC Pink®) announced today that it has obtained preliminary results from the use of Photo Dynamic Therapy (“PDT”) to destroy bla...
Brian C. Wilson Joins Theralase Medical and Scientific Advisory Board
Press ReleaseToronto, Ontario – December 16, 2014 Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Pink®) announced today that Brian C. Wilson, PhD has agreed to join the Theralase Medical and Scientific Advisory Board (“MSAB...
University of Toledo Validates University Health Network In-Vitro Data
Press ReleaseToronto, Ontario – December 9, 2014 Theralase Technologies Inc. (“Theralase”) (TSXV: TLT) (TLTFF: OTC Pink®) announced today that the University of Toledo has conducted in-vitro Photo Dynamic Compound (“PDC”) experimentation t...
Dr. Michael A. O’Donnell Joins Theralase Medical and Scientific Advisory Board
Press ReleaseToronto, Ontario – December 3, 2014 Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Link®) announced today that Michael A. O’Donnell, MD, Professor of Urology, University of Iowa located in Iowa City, Iowa has a...
Dr. Ashish M. Kamat Joins Theralase Medical and Scientific Advisory Board
Press ReleaseToronto, Ontario – December 2, 2014 Theralase Technologies Inc. (“Theralase”) (TLT:TSXV) (TLTFF: OTC Link®) announced today that Ashish M. Kamat, MD, MBBS, FACS, has agreed to join the Theralase Medical and Scientific Advisory Boa...
in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
